IGANTET

This brand name is authorized in Poland, Singapore

Active ingredients

The drug IGANTET contains one active pharmaceutical ingredient (API):

1 Tetanus immunoglobulin
UNII V4SWI4RF4J - HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN

Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus.

Read about Tetanus immunoglobulin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J06BB02 Tetanus immunoglobulin J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100122970, 100123047
Country: SG Health Sciences Authority Identifier(s): 12556P, 12557P

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.